Avita Medical Shareholders Support Leadership and Strategy
Company Announcements

Avita Medical Shareholders Support Leadership and Strategy

Avita Medical (RCEL) just unveiled an announcement.

AVITA Medical, Inc. successfully conducted its 2024 Annual Meeting virtually, with stockholders electing all seven proposed directors and ratifying the appointment of Grant Thornton LLP as the independent auditor. Additionally, stockholders approved equity awards for non-executive directors and the CEO, consisting of both restricted stock units and options. The non-binding advisory vote also saw stockholders endorse the compensation of the company’s named executive officers, reflecting a proactive governance and compensation strategy that aligns with shareholder interests.

Find detailed analytics on RCEL stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAvita Medical price target raised to $12 from $9 at Piper Sandler
TipRanks Auto-Generated NewsdeskAvita Medical Reports Strong Q3 Revenue Growth
TheFlyAvita Medical reports Q3 EPS (62c), consensus (44c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App